Collectively, our bioinformatics results strongly support that the TGFΒ3/GLI2/YAP1 expression level is significantly associated with tumor-infiltrating CAFs, T cell desertion, and immunosuppressive phenotypes and is resistant to immunotherapy in bladder cancer. The gene discussed is YAP1; the disease is urinary bladder cancer.